News
Rivercyte presents at MedtechSUMMIT 2024
2024-05-15Our founders Shada Hofemeier Abuhattum and Martin Kräter presented the Naiad and our data analysis solutions at MedtechSUMMIT 2024 in Regensburg. The event, centered on "Digitale Diagnostik - Die transformative Kraft von KI in der Diagnostik?", highlighted AI's transformative impact on digital diagnostics, discussing challenges and innovative solutions.
Rivercyte showcases the Naiad at the “Mechanics of Life” symposium at EMBL Heidelberg
2024-04-18Rivercyte showcased their Naiad device at the "Mechanics of Life" symposium at EMBL Heidelberg, demonstrating their deformability cytometry technology. The symposium, focused on the role of mechanical forces from molecules to organs in development and disease, was attended by an interdisciplinary audience. Rivercyte cofounders Martin Kräter and Markéta Kubánková presented projects on deformability cytometry, including a method for diagnosing colon cancer biopsies using AI and TissueGrinder.
Rivercyte partners with leading institutions on innovative neonatal diagnostics project
2024-03-01Rivercyte is collaborating with University Hospital Erlangen and the Max Planck Institute for the Science of Light on the SoPhyA project, supported by the Bavarian State Ministry. Over three years, the project aims to enhance neonatal diagnostics using deformability cytometry to study blood cell mechanics in pediatric patients. This innovation seeks to improve early health detection and outcomes in neonatal care, supported by BayVFP funding of €319,000.
Tumour biopsy diagnostics using physical phenotyping of cells from tissues - new article out in Nature Biomedical Engineering
2023-02-09In this article published in Nature Biomedical Engineering, Soteriou and Kubankova et al. demonstrate the potential of physical phenotyping of cells for tumour biopsy diagnostics. With this approach, the physical phenotypes of singularised suspended cells dissociated from the tissue biopsy samples are analysed within 30 minutes. This sets the grounds for a new alternative to histopathological consultation during surgery, reducing time, labour and costs spent.
Physical phenotypes of cells are altered during COVID-19
2021-06-17Using deformability cytometry, Kubánková et al., at the Max-Planck-Zentrum für Physik und Medizin in Erlangen, were able to show for the first time: COVID-19 significantly changes the size and stiffness of red and white blood cells - sometimes over months. These results may help to explain why some affected people continue to experience symptoms long after an infection (long COVID).
Revolutionising cell-based diagnostics: Medical Valley Award won by interdisciplinary team of physicists, engineers and doctors
2021-04-18The mechanical properties of cells can reveal which diseases a patient is suffering from. Researchers at the Max-Planck-Zentrum für Physik und Medizin in Erlangen are taking advantage of this effect - and revolutionizing diagnostics. Their goal: instead of analyzing blood samples in few central labs, doctors should be able to do that quickly and reliably at the point-of-care. The RAPID Diagnostics project has now received the Medical Valley Award worth 250,000 euros.